Yeshiva University-Albert Einstein College of Medicine: Novel Therapy for Acute Migraine Shows Promise in Phase 3 Clinical Trial
July 11, 2019
July 11, 2019
BRONX, New York, July 11 [TNSmedicalresearch] -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
* * *
- New England Journal of Medicine Paper Confirms That Treatment Eliminates Pain and Other Symptoms
* * *
A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in th . . .
* * *
- New England Journal of Medicine Paper Confirms That Treatment Eliminates Pain and Other Symptoms
* * *
A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in th . . .